The critical conditions of lower back pain which require surgical intervention are quite complicated and has chances of hindering the biomechanics of the whole vertebral column, making it a temporary solution.


What the world needed was a more permanent solution and the one to come up with a relatively effective innovation was a biomedical engineer from IIT Delhi Sumit Murab. While pursuing his PhD at IIT Delhi, Sumit researched that most of the elderly patients suffering from arthritis are been given a drug called glucosamine to control the pain. But what left him flabbergasted was the fact that this drug was administered in a much higher quantity than required. The drug had to be taken orally and it not only affected the particular part that had to be treated but the whole body, which made it less effective and also developed a risk of major side effects.

Read this Single Story

Rs. 10

Get instant access to this article and read about Injectable’s incredible work


Read Single Issue 31 

Rs. 50

Get instant access to the full e-paper version of Issue 31 including this story


Subscribe to the Yearly Pack

Rs. 400 per year

Get 12 Issues of The Optimist Citizen delivered at your doorsteps every month


No Comment

Leave a reply

Your email address will not be published. Required fields are marked *